Citation:Van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, et al 2016

From Cancer Guidelines Wiki

Citation


van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, et al. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. J Clin Oncol 2016 May 20;34(15):1723-31 Available from: http://www.ncbi.nlm.nih.gov/pubmed/26903575.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Liver-directed therapies for patients with incurable metastatic colorectal cancerMelissa Chowcompleted
Liver-directed therapies for patients with incurable metastatic colorectal cancerBen Lee-Batescompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Liver directed therapies unresectable metastatic CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Liver directed therapies unresectable metastatic CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Liver directed therapies unresectable metastatic CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Liver directed therapies unresectable metastatic CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Liver-directed therapies for patients with incurable metastatic colorectal cancer